Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
- 12 September 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 67 (5), 908-910
- https://doi.org/10.1212/01.wnl.0000230215.41296.18
Abstract
The synucleinopathies are neurodegenerative disorders defined by inclusions composed of aberrantly fibrillized α-synuclein, but factors contributing to this process remain largely unknown. The authors examined the glucocerebrosidase gene in 75 autopsy specimens with different synucleinopathies and identified mutations in 23% of cases of dementia with Lewy bodies, expanding on previous findings in subjects with Parkinson disease. Mutations in this lysosomal protein may interfere with the clearance or promote aggregation of α-synuclein.Keywords
This publication has 7 references indexed in Scilit:
- Parkinsonism among Gaucher disease carriersJournal of Medical Genetics, 2004
- Mutations in the Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi JewsNew England Journal of Medicine, 2004
- Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated AutophagyScience, 2004
- Neuropathology provides clues to the pathophysiology of Gaucher diseaseMolecular Genetics and Metabolism, 2004
- Glucocerebrosidase mutations in subjects with parkinsonismMolecular Genetics and Metabolism, 2004
- Gaucher disease with parkinsonian manifestations: does glucocerebrosidase deficiency contribute to a vulnerability to parkinsonism?Molecular Genetics and Metabolism, 2003
- SynucleinopathiesArchives of Neurology, 2001